Industry News
Improved treatment for dermatitis in cancer patients
Dec 11, 2014
Researchers have shown how a topical steroid cream frequently used to treat common skin conditions, can be used to improve dermatitis in cancer patients. Read More
Vast majority of ophthalmologists treating uveal melanoma use molecular testing to guide patient care
Dec 11, 2014
Castle Biosciences Inc. has announced the publication of study results that assess current clinical practices for uveal melanoma (UM) and demonstrate the impact of molecular prognostic testing on... Read More
Immunotherapy shows clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation
Dec 11, 2014
A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation... Read More
Agent THZ1 causes small cell lung tumors to shrink in pre-clinical testing
Dec 11, 2014
Small cell lung cancer - a disease for which no new drugs have been approved for many years - has shown itself vulnerable to an agent that disables part of tumor cells' basic survival machinery... Read More
Potential to predict which patients are at risk of developing therapy-related acute myeloid leukemia
Dec 11, 2014
For a small percentage of cancer patients, treatment aimed at curing the disease leads to a form of leukemia with a poor prognosis. Read More
A defining characteristic of cancer is disorder in the gene-control system
Dec 11, 2014
The genetic tumult within cancerous tumors is more than matched by the disorder in one of the mechanisms for switching cells' genes on and off, scientists at Dana-Farber Cancer Institute and the... Read More
New technology can improve sickle cell disease outcomes
Dec 11, 2014
Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine presented new research findings at the 56th Annual... Read More
Sleeping Beauty gene study shows encouraging results in patients with lymphoid malignancies
Dec 11, 2014
Study results of CD19-directed chimeric antigen receptor (CAR) therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with... Read More
Combination chemotherapy for aggressive acute myeloid leukemia reduces adverse effects; older patient population benefits
Dec 11, 2014
Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin. Read More
Comparison of blood clot treatments illuminate recurrence risk in high-risk groups
Dec 11, 2014
Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in... Read More
Previous Page Next Page